| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |